Press release
Self-amplifying RNA (saRNA) Drugs Market: Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports
Self-amplifying RNA (saRNA) Drugs MarketsaRNA is an RNA that shares many structural similarities with mRNA: it is a linear, single-stranded RNA molecule synthesized from a 5' cap, a 3' poly(A) tail, and 5' and 3' UTRs. The main difference is that saRNA is a larger molecule because it encodes four additional proteins in addition to the vaccine antigen or gene of interest. These four additional proteins are nonstructural proteins, usually derived from alphaviruses, encoding replicase enzymes. This replicase is able to amplify the original RNA strand upon delivery to cells, resulting in higher amounts of protein expression with minimal RNA dosage required.
The global Self-amplifying RNA (saRNA) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Self-amplifying RNA (saRNA) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Self-amplifying RNA (saRNA) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Self-amplifying RNA (saRNA) Drugs include Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna and CSL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Self-amplifying RNA (saRNA) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-amplifying RNA (saRNA) Drugs.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-6S16968/Global_Self_amplifying_RNA_saRNA_Drugs_Market_Research_Report_2024
Report Scope
The Self-amplifying RNA (saRNA) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Self-amplifying RNA (saRNA) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-amplifying RNA (saRNA) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-6S16968/Global_Self_amplifying_RNA_saRNA_Drugs_Market_Research_Report_2024
Segment by Type
• Preventive Medicine
• Medicine
Segment by Application
• Infectious Disease
• Cancer
• Others
By Company
Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics
View full report
https://reports.valuates.com/market-reports/QYRE-Auto-6S16968/global-self-amplifying-rna-sarna-drugs
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Self-amplifying RNA (saRNA) Drugs Market: Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports here
News-ID: 3612514 • Views: …
More Releases from Valuates Reports
Asynchronous Dual-Port DRAM Market Share Driven by High-Speed Data Access and Pa …
Asynchronous Dual-Port DRAM Market Size
The global market for Asynchronous Dual-Port DRAM was valued at US$ 374 million in the year 2024 and is projected to reach a revised size of US$ 537 million by 2031, growing at a CAGR of 5.3% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-14L20033/Global_Asynchronous_Dual_Port_DRAM_Market_Research_Report_2025
The Asynchronous Dual-Port DRAM Market is gaining steady market growth as industries increasingly rely on memory solutions that support simultaneous read and write operations…
β-Nicotinamide Mononucleotide (NMN) Market Share Driven by Expanding Health Sup …
β-Nicotinamide Mononucleotide (NMN) Market Size
The global market for β-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-16K9169/Global_%CE%B2_Nicotinamide_Mononucleotide_NMN_Market_Insights_and_Forecast_to_2028
The β-Nicotinamide Mononucleotide (NMN) Market is experiencing notable market growth as interest in cellular health, healthy aging, and metabolic support continues to rise across…
Aluminium Foil Market Share Driven by Packaging Demand, Energy Efficiency, and E …
Aluminium Foil - Market Size
The global market for Aluminium Foil was estimated to be worth US$ 21620 million in 2023 and is forecast to a readjusted size of US$ 29320 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-4P1801/Global_Aluminium_Foil_Market_Insights_and_Forecast_to_2028
The Aluminium Foil Market continues to demonstrate resilient market growth, supported by its essential role across packaging, thermal management, and advanced electrical applications. Market trends reflect…
DNA Data Storage Market Share Driven by Exponential Data Generation and Advances …
DNA Data Storage Market
The global market for DNA Data Storage was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-29Y8377/Global_DNA_Data_Storage_Market_Insights_Forecast_to_2028
The DNA Data Storage Market is emerging as a transformative solution for long-term, high-density data preservation, driven by the rapid growth of digital information and limitations of…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
